These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 22955007)

  • 1. Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation.
    Howes OD; Vergunst F; Gee S; McGuire P; Kapur S; Taylor D
    Br J Psychiatry; 2012 Dec; 201(6):481-5. PubMed ID: 22955007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders.
    Thompson JV; Clark JM; Legge SE; Kadra G; Downs J; Walters JT; Hamshere ML; Hayes RD; Taylor D; MacCabe JH
    J Psychopharmacol; 2016 May; 30(5):436-43. PubMed ID: 26905920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.
    Ganguly R; Kotzan JA; Miller LS; Kennedy K; Martin BC
    J Clin Psychiatry; 2004 Oct; 65(10):1377-88. PubMed ID: 15491242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinations.
    Velligan DI; Carroll C; Lage MJ; Fairman K
    Psychiatr Serv; 2015 Feb; 66(2):127-33. PubMed ID: 25321616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to Initiation of Clozapine Treatment in Children and Adolescents with Early-Onset Schizophrenia.
    Trinczek E; Heinzel-Gutenbrunner M; Haberhausen M; Bachmann CJ
    Pharmacopsychiatry; 2016 Nov; 49(6):254-259. PubMed ID: 27737473
    [No Abstract]   [Full Text] [Related]  

  • 6. Switching from clozapine to paliperidone palmitate-3-monthly improved obesity, hyperglycemia and dyslipidemia lowering antipsychotic dose equivalents in a treatment-resistant schizophrenia cohort.
    Martínez-Andrés JA; García-Carmona JA
    Int Clin Psychopharmacol; 2020 May; 35(3):163-169. PubMed ID: 31851035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delay in initiation of clozapine: a retrospective study from a tertiary care hospital in North India.
    Grover S; Hazari N; Chakrabarti S; Avasthi A
    Psychiatry Res; 2015 Mar; 226(1):181-5. PubMed ID: 25619433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of clozapine prescribing in a mental health service in New Zealand.
    Harrison J; Janlöv M; Wheeler AJ
    Pharm World Sci; 2010 Aug; 32(4):503-11. PubMed ID: 20526811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic prescribing pathways, polypharmacy, and clozapine use in treatment of schizophrenia.
    Gören JL; Meterko M; Williams S; Young GJ; Baker E; Chou CH; Kilbourne AM; Bauer MS
    Psychiatr Serv; 2013 Jun; 64(6):527-33. PubMed ID: 23450334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review.
    Taylor DM; Young C; Paton C
    J Clin Psychiatry; 2003 Jan; 64(1):30-4. PubMed ID: 12590620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-Year Outcome and Adherence to Pharmacological Guidelines in First-Episode Schizophrenia: Results From a Consecutive Cohort Study.
    Drosos P; Brønnick K; Joa I; Johannessen JO; Johnsen E; Kroken RA; Stain HJ; Hegelstad WTV; Larsen TK
    J Clin Psychopharmacol; 2020; 40(6):534-540. PubMed ID: 33136922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine users in Australia: their characteristics and experiences of care based on data from the 2010 National Survey of High Impact Psychosis.
    Siskind DJ; Harris M; Phillipou A; Morgan VA; Waterreus A; Galletly C; Carr VJ; Harvey C; Castle D
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):325-337. PubMed ID: 27426892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study.
    Kroken RA; Johnsen E; Ruud T; Wentzel-Larsen T; Jørgensen HA
    BMC Psychiatry; 2009 May; 9():24. PubMed ID: 19445700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine treatment and discontinuation in Iceland: A national longitudinal study using electronic patient records.
    Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E
    Nord J Psychiatry; 2016 Aug; 70(6):450-5. PubMed ID: 27049594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacy.
    Honer WG; Procyshyn RM; Chen EY; MacEwan GW; Barr AM
    J Psychiatry Neurosci; 2009 Nov; 34(6):433-42. PubMed ID: 19949719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the risk of antipsychotic polypharmacy discontinuation dependent on the agents used?
    Constantine RJ; Andel R; McPherson M; Tandon R
    Psychiatry Res; 2018 May; 263():238-244. PubMed ID: 29195836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Clozapine Delay on Clinical Outcomes in Schizophrenia.
    Law C; See YM; Yee JY; Ng BT; Tang C; Lee J
    J Clin Psychiatry; 2023 Aug; 84(5):. PubMed ID: 37616477
    [No Abstract]   [Full Text] [Related]  

  • 19. Delays and barriers to the commencement of clozapine in eligible people with a psychotic disorder: A literature review.
    Thien K; O'Donoghue B
    Early Interv Psychiatry; 2019 Feb; 13(1):18-23. PubMed ID: 29984888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review.
    Shah P; Iwata Y; Plitman E; Brown EE; Caravaggio F; Kim J; Nakajima S; Hahn M; Remington G; Gerretsen P; Graff-Guerrero A
    Psychiatry Res; 2018 Oct; 268():114-122. PubMed ID: 30015109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.